---
category: corporate-action
circular_id: 94c6b5bae905fda0
date: '2026-01-21'
description: DR LALCHANDANI LABS LIMITED announces 1:1 rights issue at par value of
  Rs.10 per share with record date on January 27, 2026.
draft: false
guid: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={2B42EAF5-7BDD-4E72-9316-67E1CF24E2B3}&noticeno=20260121-50&dt=01/21/2026&icount=50&totcount=58&flag=0
impact: medium
impact_ranking: medium
importance_ranking: medium
justification: Standard rights issue announcement affecting existing shareholders
  of DR LALCHANDANI LABS LIMITED with 1:1 ratio at par value
pdf_url: https://www.bseindia.com/markets/MarketInfo/DownloadAttach.aspx?id=20260121-50&attachedId=
processing:
  attempts: 1
  content_hash: 8dd41ba95f537184
  processed_at: '2026-01-21T18:56:20.462909'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2026-01-21T14:19:03+00:00'
rss_url: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={2B42EAF5-7BDD-4E72-9316-67E1CF24E2B3}&noticeno=20260121-50&dt=01/21/2026&icount=50&totcount=58&flag=0
severity: medium
source: bse
stocks:
- '541299'
tags:
- rights-issue
- corporate-action
- equity-shares
- record-date
- ex-rights
title: Rights Issue of DR LALCHANDANI LABS LIMITED - Record Date January 27, 2026
---

## Summary

BSE has notified that DR LALCHANDANI LABS LIMITED (Scrip Code: 541299) has fixed the record date for its rights issue of equity shares. The company will issue 1 equity share of Rs.10 each for every 1 equity share held, at par value. Trading in the company's shares will commence on ex-rights basis from January 27, 2026.

## Key Points

- Rights ratio: 1:1 (One new equity share for every one equity share held)
- Issue price: Rs.10 per share (at par)
- Payment terms: Entire issue price of Rs.10 per share payable on application
- Security type: Equity shares of Rs.10 each
- Settlement number: DR-806/2025-2026

## Regulatory Changes

No regulatory changes introduced by this circular.

## Compliance Requirements

- Trading members must ensure transactions in DR LALCHANDANI LABS LIMITED shares are conducted on ex-rights basis from January 27, 2026
- Trading members are required to take note of the record date and ex-rights date for proper settlement

## Important Dates

- **Notice Date**: January 21, 2026
- **Record Date**: January 27, 2026
- **Ex-Rights Date**: January 27, 2026
- **Settlement Number**: DR-806/2025-2026

## Impact Assessment

**Market Impact**: Medium - The 1:1 rights issue will potentially double the equity base of DR LALCHANDANI LABS LIMITED. Existing shareholders have the opportunity to maintain their proportional ownership by subscribing to the rights issue.

**Shareholder Impact**: Existing shareholders as of the record date (January 27, 2026) will be eligible to participate in the rights issue. The share price is expected to adjust for the ex-rights basis from January 27, 2026.

**Liquidity Impact**: Trading on ex-rights basis from January 27, 2026 may cause price adjustment to reflect the rights entitlement separation from the stock price.